The global portable ultrasound devices market size was valued at USD 1.70 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 5.6% from 2022 to 2030. Increased advancements in medical technology, a rise in a patient’s preference for minimally invasive treatments, and extensive adoption of imaging systems in emergency care are some of the key factors driving the market. Portable ultrasound devices are advanced ultrasound machines that can be utilized in hospitals and clinics and are designed to make the practice easier for healthcare professionals.
Portable ultrasound devices are used in non-invasive and minimally invasive surgical (MIS) treatments as they can ablate abnormal tissue from a wide-angle during diagnosis. To improve patient care and prevent excessive bleeding or infection, surgical treatments are widely being performed with minimally invasive techniques or keyhole procedures. The COVID-19 outbreak had a combined impact on the healthcare sector as some markets such as the fertility market was negatively impacted and others such as the mechanical ventilators market witnessed an increase in demand in 2020.
In the early days of the pandemic, some countries implemented lockdowns that significantly hampered the ability to carry out routine medical treatments. This led to an enormous reduction in hospital visits and the termination of a significant number of diagnostic methods, such as ultrasound imaging. As a result, the global market witnessed a negative impact as the number of patients seeking diagnosis and treatments dropped drastically.
The handheld ultrasound devices segment accounted for the largest revenue share of over 55.0% in 2021 and is also expected to register the fastest CAGR over the forecast period owing to the enhanced picture quality as technology continues to grow. High-end ultrasound devices are expensive, difficult to move, and sometimes only accessible in specialized medical wards considering their diagnostic value. These are the smallest possible ultrasound equipment that can fit inside a physician's coat pocket. Hand-held ultrasound devices are less expensive than console ultrasound units, and are convenient for professionals to carry.
Laptop-based ultrasound devices can be utilized at the bedside either on a cart or by hand due to their small designs. These devices have advanced imaging capabilities and strong battery power backup and offer benefits that justify their cost. The compact size of these ultrasound devices avoids stretching time and controls with easy reach. Clinical efficiency has been improved by advanced miniature technology in a wide range of medical applications.
The obstetrics/gynecology segment dominated the market and held a revenue share of over 45.0% in 2021. Hand-held and laptop-based devices with high-end imaging techniques are crucial in most cases. Portable ultrasound devices are also flexible and easy to use by expectant parents. For instance, in 2021, GE Healthcare launched Vscan Extend, a handheld ultrasound device, which helps doctors to examine the heart rate of the fetus, evaluate its position, check fluid levels, determine uterine fibroids, and evaluate the health of the mother, including any potential cardiac issues.
The cardiovascular segment is estimated to register a CAGR of 7.1% over the forecast period due to the increasing prevalence of cardiovascular disorders (CVD) globally. As per the American Heart Association, cardiovascular disease (CVD), registered as the underlying cause of demises, accounted for 868,662 deaths in the U.S. in 2017.
The Doppler portable ultrasound segment dominated the market and held a revenue share of over 45.0% in 2021 owing to its high-resolution medical screen that uses sub-array component transducers and multi-beam parallel technology. Doppler ultrasound imaging is a noninvasive diagnostic procedure that uses flowing red blood cells to reflect high-frequency sound radiation (ultrasound) to assess the blood flow in the blood arteries. This technique can be performed as a substitute for invasive treatments like angiography, which injects dye into the blood arteries to make them visible on X-ray images. The doctors are using a Doppler ultrasound to assess artery damage or to keep track of specific vein and artery therapies.
The 3D and 4D portable ultrasound segment is estimated to register the fastest CAGR of 8.0% over the forecast period. Imaging options in 3D and 4D are more sophisticated than those in 2D. Although almost all medical specialties use ultrasonography, 3D and 4D imaging are frequently connected to pregnancy. The thought of being able to watch a fetus develop and grow in great detail excites expectant moms. Prenatal 3D ultrasound can be used to identify exterior abnormalities such as cleft lip or spinal curvature. It is an exceptional technology for examining the fetal heart's structural components.
The hospital and clinics segment dominated the market and held a revenue share of over 55.0% in 2021. This is due to their smaller size and more exact image quality. Doctors have started carrying body-imaging solutions in the form of moveable ultrasounds to remote medical centers. Hospitals and clinics with dependable power sources and limited space for large equipment are now able to use ultrasound. Portable ultrasound technology is still in its development phase, but it has expanded quickly and already accounts for a sizable portion of the ultrasound market.
The home care segment is expected to register a CAGR of 7.0% over the forecast period. Ultrasound technology moving from the clinical setting to the home setting is a widely adopted trend that has been developing slowly over the past few years. It is the responsibility of doctors, however, for patients with certain conditions who require to be scanned more often, they should receive handheld portable devices as well as basic training at home. This would let them scan themselves at a particular frequency and send the images directly to the physician, which is indicated to be safer, more efficient, and less expensive in the long run.
North America dominated the market and accounted for a revenue share of over 40.0% in 2021. Rapid advancements in the medical sector, allocation of funds for medical research, and developments are some of the key factors contributing to regional market growth. The presence of a significant number of market competitors and the developed healthcare infrastructure are some of the key factors contributing to the regional market growth.
Asia Pacific is expected to be the fastest-growing market with a CAGR of 6.7% over the forecast period. The increasing population in the region and lifestyle habits are leading to a rise in the number of people with diseases. For instance, in China, the population over the age of 65 is anticipated to increase from 164.48 million in 2019 to 246.98 million by 2030, as per the World Population Ageing 2019 study. Medical device companies across the globe are entering the Asia Pacific market to expand their businesses due to lower manufacturing costs, market opportunities, and the large population in the region.
The leading companies are attempting to enhance their product portfolio by upgrading their products, utilizing significant cooperative efforts, and investigating acquisitions and government permissions to increase their client base and capture a larger share of the market. Furthermore, they are adopting strategies such as partnerships, mergers and acquisitions, product and service launches, agreements, joint ventures, collaborations, and expansions to strengthen their position in the market.
For instance, in February 2022, FUJIFILM launched Sonosite LX, the most advanced luxury point-of-care ultrasound system, to increase diagnostic and procedural confidence. Sonosite LX combines the organization's largest clinical imaging to date with proprietary enhanced picture clarity. It also comes with an adjustable monitor and touch interface to foster better teamwork.
In February 2022, Philips launched a handheld point-of-care ultrasound, named Lumify. The firm specializes in health technology and now it features increased hemodynamic evaluation and measuring capabilities. With the addition of Pulse Wave Doppler, Philips has significantly increased the functionality of its handheld portable ultrasound, Lumify, which allows clinicians to measure blood flow in a variety of point-of-care diagnostic and therapeutic applications, including vascular, cardiology, urology, abdominal, obstetrics, and, gynecology. Some prominent players in the global portable ultrasound devices market include:
General Electric Company
Siemens
Koninklijke Philips N.V.
SAMSUNG
FUJIFILM Holdings Corporation
Shenzhen Mindray Bio-medical Electronics Co., Ltd.
Canon Inc.
BenQ Corporation
Report Attribute |
Details |
Market size value in 2022 |
USD 2.04 billion |
Revenue forecast in 2030 |
USD 3.15 billion |
Growth rate |
CAGR of 5.6% from 2022 to 2030 |
Base year for estimation |
2021 |
Historical data |
2017 - 2020 |
Forecast period |
2022 - 2030 |
Quantitative units |
Revenue in USD million/billion and CAGR from 2022 to 2030 |
Report coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
Segments covered |
Type, application, technology, end-use, region |
Regional scope |
North America; Europe; Asia Pacific; Latin America; MEA |
Country scope |
U.S.; Canada; U.K.; Germany; France; Italy; Spain; China; Japan; India; Brazil; Mexico; South Africa |
Key companies profiled |
GE Healthcare; Siemens; Koninklijke Philips N.V.; Samsung; FUJIFILM Holdings Corporation; Shenzhen Mindray Bio-medical Electronics Co., Ltd.; Canon Inc.; BenQ Corporation |
Customization scope |
Free report customization (equivalent up to 8 analyst’s working days) with purchase. Addition or alteration to country, regional, and segment scope |
Pricing and purchase options |
Avail customized purchase options to meet your exact research needs. Explore purchase options |
This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2017 to 2030. For this study, Grand View Research has segmented the global portable ultrasound devices market report based on type, application, technology, end-use, and region:
Type Outlook (Revenue, USD Million, 2017 - 2030)
Laptop-based
Handheld
Application Outlook (Revenue, USD Million, 2017 - 2030)
Obstetrics/Gynecology
Cardiovascular
Urology
Gastric
Musculoskeletal
Others
Technology Outlook (Revenue, USD Million, 2017 - 2030)
2D Ultrasound
3D & 4D Ultrasound
Doppler Ultrasound
High-intensity Focused Ultrasound
End-use Outlook (Revenue, USD Million, 2017 - 2030)
Hospitals & Clinics
Home Care
Others
Regional Outlook (Revenue, USD Million, 2017 - 2030)
North America
U.S.
Canada
Europe
U.K.
Germany
France
Italy
Spain
Asia Pacific
Japan
China
India
Latin America
Brazil
Mexico
Middle East and Africa
South Africa
b. The global portable ultrasound devices market size was estimated at USD 1.70 billion in 2021 and is expected to reach USD 2.04 billion in 2022.
b. The global portable ultrasound systems market is expected to grow at a compound annual growth rate of 5.6% from 2022 to 2030 to reach USD 3.15 billion by 2030.
b. North America dominated the portable ultrasound devices market with a share of 41% in 2021. This is attributable to rising healthcare awareness coupled with cloud-based technology acceptance and research and development initiatives.
b. Some key players operating in the portable ultrasound devices market include GE Healthcare, Siemens, Koninklijke Philips N.V., Samsung, FUJIFILM Holdings Corporation, Shenzhen Mindray Bio-medical Electronics Co., Ltd, Canon Inc, and BenQ, among others.
b. Key factors driving the market growth include increased advancements in medical technology, a rise in a patient’s preference for minimally invasive treatments, and extensive adoption of imaging systems in emergency care.
GET A FREE SAMPLE
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.
Contact us now to get our best pricing.
ESOMAR certified & member
Leading SME award by D&B
We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.
"The quality of research they have done for us has been excellent."
We value your investment and offer free customization with every report to fulfil your exact research needs.